ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives

RECENT NEWS

ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

2026-05-27

READ MORE >

ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance

2026-05-08

READ MORE >

NASDAQ - ANIP

$82.64

+ 1.44 (1.77%)

Pricing delayed by 20 minutes
Last updated 2026-06-10 12:30:00